Literature DB >> 26498652

Obestatin stimulates differentiation and regulates lipolysis and leptin secretion in rat preadipocytes.

Tatiana Wojciechowicz1, Marek Skrzypski1, Paweł A Kołodziejski1, Dawid Szczepankiewicz1, Ewa Pruszyńska-Oszmałek1, Przemysław Kaczmarek1, Mathias Z Strowski2, Krzysztof W Nowak1.   

Abstract

Obestatin is a 23-amino acid peptide encoded by the ghrelin gene, which regulates food intake, body weight and insulin sensitivity. Obestatin influences glucose and lipid metabolism in mature adipocytes in rodents. However, the role of this peptide in rat preadipocytes remains to be fully understood. The current study characterized the effects of obestatin on lipid accumulation, preadipocyte differentiation, lipolysis and leptin secretion in rat primary preadipocytes. Obestatin enhanced lipid accumulation in rat preadipocytes and increased the expression of surrogate markers of preadipocyte differentiation. At the early stage of differentiation, obestatin suppressed lipolysis. By contrast, lipolysis was stimulated at the late stage of adipogenesis. Furthermore, obestatin stimulated the release of leptin, a key satiety hormone. Overall, the results indicated that obestatin promotes preadipocyte differentiation. Obestatin increased leptin release in preadipocytes, while the modulation of lipolysis appears to depend upon the stage of differentiation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26498652     DOI: 10.3892/mmr.2015.4470

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  Obestatin and Rosiglitazone Differentially Modulate Lipid Metabolism Through Peroxisome Proliferator-activated Receptor-γ (PPARγ) in Pre-adipose and Mature 3T3-L1 Cells.

Authors:  Mallikarjuna B G; Uma V Manjappara
Journal:  Cell Biochem Biophys       Date:  2021-01-11       Impact factor: 2.194

2.  Mesonosides A-H, primeverose derivatives from Mesona procumbens suppress adipogenesis by downregulating PPARγ and C/EBPα in 3T3-L1 cells.

Authors:  Hung-Tse Huang; Chia-Ching Liaw; Chun-Tang Chiou; Kung-Ta Lee; Yao-Haur Kuo
Journal:  J Food Drug Anal       Date:  2021-09-15       Impact factor: 6.157

3.  Acetate-mediated-obestatin modulation attenuates adipose-hepatic dysmetabolism in high fat diet-induced obese rat model.

Authors:  Kehinde S Olaniyi; Chukwubueze L Atuma; Isaiah W Sabinari; Hadiza Mahmud; Azeezat O Saidi; Adedamola A Fafure; Lawrence A Olatunji
Journal:  Endocrine       Date:  2022-02-28       Impact factor: 3.925

4.  Original Research: Orexins A and B stimulate proliferation and differentiation of porcine preadipocytes.

Authors:  Tatiana Wojciechowicz; Marek Skrzypski; Dawid Szczepankiewicz; Iwona Hertig; Paweł A Kołodziejski; Maria Billert; Mathias Z Strowski; Krzysztof W Nowak
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

5.  Short-term effects of obestatin on hexose uptake and triacylglycerol breakdown in human subcutaneous adipocytes.

Authors:  Christian Carpéné; Francisco Les; David Estève; Jean Galitzky
Journal:  World J Diabetes       Date:  2018-01-15

6.  Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients.

Authors:  Anita Szentpéteri; Hajnalka Lőrincz; Sándor Somodi; Viktória Evelin Varga; György Paragh; Ildikó Seres; György Paragh; Mariann Harangi
Journal:  Lipids Health Dis       Date:  2018-03-05       Impact factor: 3.876

Review 7.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

8.  Chain length of dietary fatty acids determines gastrointestinal motility and visceromotor function in mice in a fatty acid binding protein 4-dependent manner.

Authors:  Paula Mosińska; Adrian Szczepaniak; Tatiana Wojciechowicz; Marek Skrzypski; Krzysztof Nowak; Jakub Fichna
Journal:  Eur J Nutr       Date:  2019-09-27       Impact factor: 5.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.